These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
84 related items for PubMed ID: 19469294
1. [Interest of bone alkaline phosphatase in hemodialysis patients]. Helal I, Bahlous A, El Younsi F, Ben Hamida F, Abdelmoula J, Belkahia C, Kheder A. Tunis Med; 2008 May; 86(5):427-30. PubMed ID: 19469294 [Abstract] [Full Text] [Related]
2. [Alkaline phosphatase of bone origin in hemodialyzed patients. 110 assays]. Ureña P, Prieur P, Pétrover M. Presse Med; 1996 Oct 05; 25(29):1320-5. PubMed ID: 8942941 [Abstract] [Full Text] [Related]
3. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. Ureña P, Hruby M, Ferreira A, Ang KS, de Vernejoul MC. J Am Soc Nephrol; 1996 Mar 05; 7(3):506-12. PubMed ID: 8704118 [Abstract] [Full Text] [Related]
4. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children. Baskin E, Beşbaş N, Saatçi U, Hasçelik G, Topaloğlu R, Ozen S, Bakkaloğlu A. Turk J Pediatr; 2004 Mar 05; 46(1):28-31. PubMed ID: 15074371 [Abstract] [Full Text] [Related]
5. [Diagnostic accuracy study comparing total alkaline phosphatase with intact parathyroid hormone 1-84 for the diagnosis of high turnover renal osteodystrophy in chronic renal failure on hemodialysis]. Rojas González AM, Opazo Valenzuela M, Muñoz Navarro S. Medwave; 2014 Sep 03; 14(8):e6014. PubMed ID: 25340338 [Abstract] [Full Text] [Related]
6. [Study of renal osteodystrophy by bone biopsy. Age as an independent factor. Diagnostic value of bone remodeling markers]. Jarava C, Armas JR, Palma A. Nefrologia; 2000 Sep 03; 20(4):362-72. PubMed ID: 11039262 [Abstract] [Full Text] [Related]
7. Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology. Fletcher S, Jones RG, Rayner HC, Harnden P, Hordon LD, Aaron JE, Oldroyd B, Brownjohn AM, Turney JH, Smith MA. Nephron; 1997 Sep 03; 75(4):412-9. PubMed ID: 9127327 [Abstract] [Full Text] [Related]
8. Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients. Kobayashi I, Shidara K, Okuno S, Yamada S, Imanishi Y, Mori K, Ishimura E, Shoji S, Yamakawa T, Inaba M. Life Sci; 2012 Jan 30; 90(5-6):212-8. PubMed ID: 22154904 [Abstract] [Full Text] [Related]
9. Renal osteodystrophy in Ramathibodi Hospital: histomorphometry and clinical correlation. Changsirikulchai S, Domrongkitchaiporn S, Sirikulchayanonta V, Ongphiphadhanakul B, Kunkitti N, Stitchantrakul W, Radienahamed P. J Med Assoc Thai; 2000 Oct 30; 83(10):1223-32. PubMed ID: 11143489 [Abstract] [Full Text] [Related]
10. Bone alkaline phosphatase besides intact parathyroid hormone in hemodialysis patients--any advantage? Jorge C, Gil C, Possante M, Silva E, Andrade R, Santos N, Cruz A, Teixeira R, Ferreira A. Nephron Clin Pract; 2005 Oct 30; 101(3):c122-7. PubMed ID: 16015001 [Abstract] [Full Text] [Related]
11. Plasma bone-specific alkaline phosphatase changes in hemodialysis patients treated by alfacalcidol. Ureña P, Bernard-Poenaru O, Cohen-Solal M, de Vernejoul MC. Clin Nephrol; 2002 Apr 30; 57(4):261-73. PubMed ID: 12005242 [Abstract] [Full Text] [Related]
12. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients. Bervoets AR, Spasovski GB, Behets GJ, Dams G, Polenakovic MH, Zafirovska K, Van Hoof VO, De Broe ME, D'Haese PC. Am J Kidney Dis; 2003 May 30; 41(5):997-1007. PubMed ID: 12722034 [Abstract] [Full Text] [Related]
13. Bone Biopsy Results in Chronic Kidney Disease: a Single-Center Experience. Liangos O, Kirchhoff S, Buchholz J, Ketteler M. Kidney Blood Press Res; 2018 May 30; 43(4):1222-1230. PubMed ID: 30071519 [Abstract] [Full Text] [Related]
14. Prevalence and pattern of renal osteodystrophy in chronic hemodialysis patients: a cross sectional study of 103 patients. Buargub MA, Nabulsi MF, Shafeh TA. Saudi J Kidney Dis Transpl; 2006 Sep 30; 17(3):401-7. PubMed ID: 16970264 [Abstract] [Full Text] [Related]
15. Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease. Doumouchtsis K, Perrea D, Doumouchtsis S, Tziamalis M, Poulakou M, Vlachos I, Kostakis A. Ther Apher Dial; 2009 Feb 30; 13(1):49-55. PubMed ID: 19379170 [Abstract] [Full Text] [Related]
16. [Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis]. Nowak Z, Konieczna M, Wańkowicz Z. Pol Merkur Lekarski; 2004 Aug 30; 17(98):138-41. PubMed ID: 15603322 [Abstract] [Full Text] [Related]
17. Evaluation of bone remodeling in hemodialysis patients: serum biochemistry, circulating cytokines and bone histomorphometry. Ferreira A, Saraiva M, Behets G, Macedo A, Galvão M, D'Haese P, Drüeke TB. J Nephrol; 2009 Aug 30; 22(6):783-93. PubMed ID: 19967658 [Abstract] [Full Text] [Related]
18. Bone histomorphometry is still the golden standard for diagnosing renal osteodystrophy. Pecovnik Balon B, Bren A. Clin Nephrol; 2000 Dec 30; 54(6):463-9. PubMed ID: 11140807 [Abstract] [Full Text] [Related]
19. Effects of calcitriol on type 5b tartrate-resistant acid phosphatase and interleukin-6 in secondary hyperparathyroidism. Lu KC, Tseng CF, Wu CC, Yeung LK, Chen JS, Chao TY, Janckila AJ, Yam LT, Chu P. Blood Purif; 2006 Dec 30; 24(5-6):423-30. PubMed ID: 16888370 [Abstract] [Full Text] [Related]
20. Bone biopsy results and serum bone turnover parameters in uremic children. Ziólkowska H, Pańiczyk-Tomaszewska M, Debiński A, Polowiec Z, Sawicki A, Sieniawska M. Acta Paediatr; 2000 Jun 30; 89(6):666-71. PubMed ID: 10914959 [Abstract] [Full Text] [Related] Page: [Next] [New Search]